Until recently, the Recombinant DNA Advisory Committee (RAC) served as the country’s highest level review body for novel biotech research safety questions. But NIH disbanded it last year. That leaves, in most circumstances, the frequently dysfunctional local Institutional Biosafety Committees (IBCs) to be the first – and last – line of defense against really stupid ideas and screw ups.Continue reading “The Quiet Death of the RAC”
The Public Access Provisions of the NIH Guidelines, as they apply to records, are short and simple. Consisting of a single paragraph, they say that Institutional Biosafety Committees (IBCs) must release to the public their meeting minutes and all other related records that their funders are required to release. Like so:
Upon request, the institution shall make available to the public all Institutional Biosafety Committee meeting minutes and any documents submitted to or received from funding agencies which the latter are required to make available to the public. If public comments are made on Institutional Biosafety Committee actions, the institution shall forward both the public comments and the Institutional Biosafety Committee’s response to the Office of Science Policy, National Institutes of Health ...
– NIH Guidelines at Section IV-B-2-a-(7)
In simple terms, what this obviously means is that, in addition to minutes, if the institution holds other records* related to rDNA research that can be obtained from a government agency under the Freedom of Information Act (or other law), then the IBC has to release those records on request. And that such records exist is effectively always the case, because nobody gets a federal grant or contract without paperwork.Continue reading “The Public Access Provisions from 1978 to 2020”